Hepion Pharmaceuticals to Unveil Groundbreaking Efficacy Data for Rencofilstat at AASLD 2023, Revolutionizing NASH Treatment
Hepion Pharmaceuticals, a leading biopharmaceutical company focused on the development of innovative therapeutics for liver diseases, has recently announced the scheduling of a conference call to review additional effic...
Nov 10, 2023
Product Service News
